Status:
COMPLETED
Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever
Lead Sponsor:
Medical Corps, Israel Defense Force
Conditions:
Relapsing Fever, Tick-borne
Jarisch Herxheimer Reaction
Eligibility:
All Genders
Phase:
PHASE2
PHASE3
Brief Summary
Abstract Background Tick-Borne Relapsing Fever (TBRF) is an acute febrile illness. In Israel, TBRF is caused by Borrelia persica and is transmitted by Ornithodoros tholozani ticks. We examined the saf...
Eligibility Criteria
Inclusion
- suspected exposure to tick-borne relapsing fever
- after returning from field exercise in a tick-borne relapsing fever infected area
- having a tick bite or staying in field in close proximity to a subject with tick bite sign
Exclusion
- known sensitivity to tetracycline or doxycycline
- febrile illness on recruitment
Key Trial Info
Start Date :
April 1 2002
Trial Type :
INTERVENTIONAL
End Date :
April 1 2003
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00237016
Start Date
April 1 2002
End Date
April 1 2003
Last Update
December 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Israel Defence Forces
Tel Litwinsky, Israel